Pharma and Biotech
Form 8.5 (EPT/RI) - Benchmark Holdings Plc | 23-Apr-2024 | 10:44 | RNS |
Rule 2.9 Announcement | 23-Apr-2024 | 07:00 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 22-Apr-2024 | 10:42 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 19-Apr-2024 | 09:23 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings Plc | 18-Apr-2024 | 10:37 | RNS |
FORM 8.3 - BENCHMARK HOLDINGS PLC | 17-Apr-2024 | 16:13 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings Plc | 17-Apr-2024 | 10:27 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings Plc | 16-Apr-2024 | 09:54 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings Plc | 11-Apr-2024 | 10:51 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings Plc | 08-Apr-2024 | 11:26 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 05-Apr-2024 | 10:38 | RNS |
Form 8.3 - Benchmark Holdings plc | 05-Apr-2024 | 09:23 | RNS |
Total Voting Rights | 28-Mar-2024 | 12:00 | RNS |
Form 8.3 - Benchmark Holdings plc | 22-Mar-2024 | 11:51 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings Plc | 22-Mar-2024 | 10:52 | RNS |
Currency | UK Pounds |
Share Price | 45.50p |
Change Today | -0.50p |
% Change | -1.09 % |
52 Week High | 47.30 |
52 Week Low | 34.00 |
Volume | 770 |
Shares Issued | 739.67m |
Market Cap | £336.55m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 2 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
No dividends found |
Time | Volume / Share Price |
10:48 | 748 @ 45.28p |
08:22 | 22 @ 45.01p |
Chair | Peter George |
CFO | Septima Maguire |
CEO | Trond Williksen |
You are here: research